Lupin Q4 PAT up 18 pc at Rs 460 crore on lower input costs

May 13, 2021

Mumbai (Maharashtra) [India], May 13 : Pharma major Lupin Ltd on Thursday reported 18 per cent jump in its consolidated profit after tax to...

Lupin completes acquisition of VISUfarma to boost European eye care portfolio

Apr 02, 2026

Lupin Ltd. has completed the acquisition of VISUfarma B.V, a European pharmaceutical company focused on ophthalmology, the company said in an exchange filing on...

Lupin launches Favipiravir in India for COVID treatment at Rs 49 per tablet

Aug 05, 2020

Mumbai (Maharashtra) [India], Aug 5 : Pharma major Lupin Ltd on Wednesday announced the launch of Favipiravir in India under the brand name Covihalt...

Lupin Q1 net profit falls 60 pc to Rs 107 cr

Aug 07, 2020

Mumbai (Maharashtra) [India], Aug 7 : Pharma major Lupin Ltd has reported 60 per cent year-on-year decline in its net profit for the April...

Lupin Ranks No. 1 Globally in Pharma; Tops All Sectors in India in S&P ESG Assessment 2025

Mar 06, 2026

Mumbai (Maharashtra) [India], March 6: Global pharma major Lupin Limited (Lupin) (BSE: 500257) (NSE: LUPIN) (REUTERS: LUPIN.BO) (BLOOMBERG: LPCIN) today announced its recognition among...

Lupin sales grow 22 pc to Rs 4,237 cr in Q1 FY22

Aug 11, 2021

Mumbai (Maharashtra) [India], August 11 : Pharma major Lupin Ltd has reported consolidated sales of Rs 4,237 crore in the first quarter of current...